Analysts applaud Intel’s massive Q1
Intel’s massive Q1 numbers and mega Q2 guidance shocked Wall Street and sent shares across the semiconductor industry higher Friday morning.
Here’s how Wall Street analysts are characterizing the far better-than-expected results:
DA Davidson (rating: “neutral,” price target: $77): “Strong 1Q26 earnings that were highlighted by a significant beat on top and bottom-line expectations. Results in the quarter reflect the growing importance of CPUs and advanced packing. We view the recent Terafab announcement as a proof point that Intel is likely to see continued customer acquisition as the United States demands more domestic semiconductor manufacturing.”
Barclays (rating: “equal weight,” price target: $65): “The sizable top-line and gross margin beat caught us by surprise as our expectation was for tight supply in Q1. Mgmt expects the supply situation to improve through the year and for yields to improve, which should support growth in server.”
HSBC (rating: “buy,” price target: $100): “The market has been
underestimating Intel’s CPU average selling price upside as well as its ability to re-allocate its own foundry capacity to unlock further CPU unit growth, considering a CPU shortage environment that we expect to persist until 2027e.”
Bernstein: (rating: “market perform,” price target: $65): “Server strength seems demonstrably real, client seems to be holding up for now, commentary around 18A/14A was positive, and there remains hopes for forthcoming packaging announcements. That being said, there were quite a few nuggets for the bears as well; namely while 18A yields are seemingly running better than expected they apparently remain underwhelming, and ASP increases are being met by cost inflation.”
JPMorgan (rating: “underweight,” price target: $45): “EPS quality issues, 2H gross margin headwinds, structural OpEx creep, and a Foundry breakeven timeline that is likely to push beyond YE CY27 keep us at UW even as we raise estimates.”
DA Davidson (rating: “neutral,” price target: $77): “Strong 1Q26 earnings that were highlighted by a significant beat on top and bottom-line expectations. Results in the quarter reflect the growing importance of CPUs and advanced packing. We view the recent Terafab announcement as a proof point that Intel is likely to see continued customer acquisition as the United States demands more domestic semiconductor manufacturing.”
Barclays (rating: “equal weight,” price target: $65): “The sizable top-line and gross margin beat caught us by surprise as our expectation was for tight supply in Q1. Mgmt expects the supply situation to improve through the year and for yields to improve, which should support growth in server.”
HSBC (rating: “buy,” price target: $100): “The market has been
underestimating Intel’s CPU average selling price upside as well as its ability to re-allocate its own foundry capacity to unlock further CPU unit growth, considering a CPU shortage environment that we expect to persist until 2027e.”
Bernstein: (rating: “market perform,” price target: $65): “Server strength seems demonstrably real, client seems to be holding up for now, commentary around 18A/14A was positive, and there remains hopes for forthcoming packaging announcements. That being said, there were quite a few nuggets for the bears as well; namely while 18A yields are seemingly running better than expected they apparently remain underwhelming, and ASP increases are being met by cost inflation.”
JPMorgan (rating: “underweight,” price target: $45): “EPS quality issues, 2H gross margin headwinds, structural OpEx creep, and a Foundry breakeven timeline that is likely to push beyond YE CY27 keep us at UW even as we raise estimates.”